Lancet Diabetes Endo:胎儿期25-羟维生素D浓度影响儿童期骨健康吗?

2017-06-06 选题审校:闫盈盈 编辑:吴刚 环球医学

胎儿期25-羟维生素D(25(OH)D)浓度对骨骼发育具有长期影响,但是既往研究的结果不一致。2017年5月,发表在《Lancet Diabetes Endocrinol.》的一项基于人群的前瞻性队列研究调查了胎儿期25-羟维生素D浓度和6岁儿童骨健康之间的相关性。

胎儿期25-羟维生素D(25(OH)D)浓度对骨骼发育具有长期影响,但是既往研究的结果不一致。2017年5月,发表在《LANCET DIABETES ENDocrinol.》的一项基于人群的前瞻性队列研究调查了胎儿期25-羟维生素D浓度和6岁儿童骨健康之间的相关性。

背景:胎儿期25(OH)D浓度对骨骼发育具有长期影响,但是既往研究的结果不一致。研究人员调查了产妇和胎儿25(OH)D浓度与童年骨健康之间的相关性。

方法:在一项嵌入到下一代R研究(荷兰鹿特丹)的前瞻性、多民族的基于人群的队列研究中,居住在研究地区的预产期为2002年4月1日~2006年1月1日的孕妇符合参加Erasmus MC索菲亚儿童医院研究中心的入组标准。研究人员检测了妊中期产妇的25(OH)D浓度(中位妊20.4周(IQR,19.9~21.1))和出生时胎儿的25(OH)D浓度(中位妊40.1周(39.3~41.0))。研究人员使用双能X线吸收法(DXA)测量了6岁儿童的全身骨矿物质密度、骨矿物质含量(BMC)、面积调整的BMC和骨面积。研究人员使用多变量线性逻辑回归检测了相关性,并调整了一些社会人口学和生活方式变量以及儿童的身高。

结果:研究人员纳入了9901个母亲儿童对,获取了4815对的妊中期产妇25(OH)D浓度和子女6岁时的DXA扫描值。与妊中期产妇25(OH)D充足(≥50nmol/L)相比,妊中期产妇25(OH)D缺乏(<25nmol/L)与6岁时较高的子女BMC(4.71g;95% CI,1.09~8.33;P=0.011)和较大的骨面积(7.54cm2;2.99~12.11;P=0.001)相关。然而,6岁时具有25(OH)D浓度数据的儿童亚组(3034人)中,调整了儿童自己的25(OH)D浓度后,BMC(4.67g;-0.05~9.39;P=0.052)和骨面积(5.25cm2;-0.41~10.91;P=0.069)的该相关性不再具有显着性。妊中期产妇25(OH)D浓度和子女骨矿物质密度(1.07mg/cm2;-1.84~3.99;P=0.47)或面积调整的BMC(-1.58g;-4.72~1.61;P=0.32)之间没有相关性,并且与6岁时的骨骼参数之间的相关性不随产妇BMI、产妇钙的摄入、儿童性别或体重状态而具有差异。出生时胎儿25(OH)D浓度观察到了相似的相关性。

结论:胎儿期25(OH)D浓度与童年BMC和骨面积之间存在负相关性,但是该相关性在调整了儿童25(OH)D状态后不再具有显着性。研究数据表明,童年时期的25(OH)D浓度比胎儿期的25(OH)D浓度与骨骼结局更相关。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1637775, encodeId=cd5b163e775b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu May 17 21:40:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828988, encodeId=cb451828988ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 17 09:40:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759996, encodeId=cd5e1e59996b2, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Sep 13 01:40:00 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901663, encodeId=d331190166387, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Mar 11 10:40:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472069, encodeId=04fe14e2069ed, content=<a href='/topic/show?id=2a4710159387' target=_blank style='color:#2F92EE;'>#骨健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101593, encryptionId=2a4710159387, topicName=骨健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e50c7204439, createdName=aids215, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493189, encodeId=8a93149318969, content=<a href='/topic/show?id=6db7102eaa' target=_blank style='color:#2F92EE;'>#25-羟维生素D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1027, encryptionId=6db7102eaa, topicName=25-羟维生素D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=123d8994856, createdName=xlwang2694, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544445, encodeId=03f31544445be, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1637775, encodeId=cd5b163e775b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu May 17 21:40:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828988, encodeId=cb451828988ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 17 09:40:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759996, encodeId=cd5e1e59996b2, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Sep 13 01:40:00 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901663, encodeId=d331190166387, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Mar 11 10:40:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472069, encodeId=04fe14e2069ed, content=<a href='/topic/show?id=2a4710159387' target=_blank style='color:#2F92EE;'>#骨健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101593, encryptionId=2a4710159387, topicName=骨健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e50c7204439, createdName=aids215, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493189, encodeId=8a93149318969, content=<a href='/topic/show?id=6db7102eaa' target=_blank style='color:#2F92EE;'>#25-羟维生素D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1027, encryptionId=6db7102eaa, topicName=25-羟维生素D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=123d8994856, createdName=xlwang2694, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544445, encodeId=03f31544445be, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
    2017-08-17 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1637775, encodeId=cd5b163e775b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu May 17 21:40:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828988, encodeId=cb451828988ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 17 09:40:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759996, encodeId=cd5e1e59996b2, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Sep 13 01:40:00 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901663, encodeId=d331190166387, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Mar 11 10:40:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472069, encodeId=04fe14e2069ed, content=<a href='/topic/show?id=2a4710159387' target=_blank style='color:#2F92EE;'>#骨健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101593, encryptionId=2a4710159387, topicName=骨健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e50c7204439, createdName=aids215, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493189, encodeId=8a93149318969, content=<a href='/topic/show?id=6db7102eaa' target=_blank style='color:#2F92EE;'>#25-羟维生素D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1027, encryptionId=6db7102eaa, topicName=25-羟维生素D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=123d8994856, createdName=xlwang2694, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544445, encodeId=03f31544445be, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1637775, encodeId=cd5b163e775b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu May 17 21:40:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828988, encodeId=cb451828988ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 17 09:40:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759996, encodeId=cd5e1e59996b2, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Sep 13 01:40:00 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901663, encodeId=d331190166387, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Mar 11 10:40:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472069, encodeId=04fe14e2069ed, content=<a href='/topic/show?id=2a4710159387' target=_blank style='color:#2F92EE;'>#骨健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101593, encryptionId=2a4710159387, topicName=骨健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e50c7204439, createdName=aids215, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493189, encodeId=8a93149318969, content=<a href='/topic/show?id=6db7102eaa' target=_blank style='color:#2F92EE;'>#25-羟维生素D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1027, encryptionId=6db7102eaa, topicName=25-羟维生素D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=123d8994856, createdName=xlwang2694, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544445, encodeId=03f31544445be, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1637775, encodeId=cd5b163e775b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu May 17 21:40:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828988, encodeId=cb451828988ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 17 09:40:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759996, encodeId=cd5e1e59996b2, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Sep 13 01:40:00 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901663, encodeId=d331190166387, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Mar 11 10:40:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472069, encodeId=04fe14e2069ed, content=<a href='/topic/show?id=2a4710159387' target=_blank style='color:#2F92EE;'>#骨健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101593, encryptionId=2a4710159387, topicName=骨健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e50c7204439, createdName=aids215, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493189, encodeId=8a93149318969, content=<a href='/topic/show?id=6db7102eaa' target=_blank style='color:#2F92EE;'>#25-羟维生素D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1027, encryptionId=6db7102eaa, topicName=25-羟维生素D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=123d8994856, createdName=xlwang2694, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544445, encodeId=03f31544445be, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
    2017-06-08 aids215
  6. [GetPortalCommentsPageByObjectIdResponse(id=1637775, encodeId=cd5b163e775b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu May 17 21:40:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828988, encodeId=cb451828988ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 17 09:40:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759996, encodeId=cd5e1e59996b2, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Sep 13 01:40:00 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901663, encodeId=d331190166387, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Mar 11 10:40:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472069, encodeId=04fe14e2069ed, content=<a href='/topic/show?id=2a4710159387' target=_blank style='color:#2F92EE;'>#骨健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101593, encryptionId=2a4710159387, topicName=骨健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e50c7204439, createdName=aids215, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493189, encodeId=8a93149318969, content=<a href='/topic/show?id=6db7102eaa' target=_blank style='color:#2F92EE;'>#25-羟维生素D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1027, encryptionId=6db7102eaa, topicName=25-羟维生素D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=123d8994856, createdName=xlwang2694, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544445, encodeId=03f31544445be, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1637775, encodeId=cd5b163e775b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu May 17 21:40:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828988, encodeId=cb451828988ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 17 09:40:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759996, encodeId=cd5e1e59996b2, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Sep 13 01:40:00 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901663, encodeId=d331190166387, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Mar 11 10:40:00 CST 2018, time=2018-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472069, encodeId=04fe14e2069ed, content=<a href='/topic/show?id=2a4710159387' target=_blank style='color:#2F92EE;'>#骨健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101593, encryptionId=2a4710159387, topicName=骨健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e50c7204439, createdName=aids215, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493189, encodeId=8a93149318969, content=<a href='/topic/show?id=6db7102eaa' target=_blank style='color:#2F92EE;'>#25-羟维生素D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1027, encryptionId=6db7102eaa, topicName=25-羟维生素D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=123d8994856, createdName=xlwang2694, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544445, encodeId=03f31544445be, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Thu Jun 08 14:40:00 CST 2017, time=2017-06-08, status=1, ipAttribution=)]

相关资讯

J Endocrinol:维生素D或可成为止痛剂、安眠药

最新研究表明,维生素D补充与良好睡眠习惯相结合可能有助于治疗与疼痛相关的大量疾病。该研究对应文章发表于最新出版的Journal of Endocrinology杂志,名为The interfaces between vitamin D, sleep and pain。指出人类维生素D摄入与吸收水平与优质的睡眠质量可以帮助包括关节炎,月经痉挛和慢性背痛等疾病的治疗。

J Allergy Clin Immun:维生素D与哮喘

在《过敏和临床免疫学杂志》上发表的一项新研究发现,在怀孕期间服用维生素D补充剂可以积极地改变新生儿的免疫系统,这可以有助于新生儿防止哮喘和呼吸道感染。英国伦敦国王学院的研究人员研究了在怀孕的第二和第三个月每天补充4,400 IU维生素D3对新生儿的影响情况。

ASCO2017:维生素D也是宝!高剂量维生素D或延缓转移性结直肠癌进展

一项由Dana-Farber癌症研究所研究人员开展的一项多机构的维生素D随机、单盲治疗癌症患者临床试验发现,高剂量微生物或可减缓转移性结直肠癌患者的疾病进展,相关研究结果发表在6月2-6日在美国芝加哥举行的第53届美国临床肿瘤学会年会(ASCO)上。

JAHA:钙补充剂有或无维生素D与缺血性卒中相关风险分析!

这项研究表明钙补充剂作为单药治疗且较高剂量时可能会增加缺血性卒中的风险,而他们与维生素D的组合似乎抵消了这种风险。

JCLA:如何准确测定25-羟基维生素D浓度?

近年来,关于维生素D的人口研究急剧增加。这些研究通常依赖于对25-羟基维生素D [25(OH)D]浓度的测定。

J Endocrinol:补充维生素D + 睡个好觉 疼痛缓解

继一项关于维生素D、睡眠与疼痛之间相互关系的研究发表之后,研究人员认为,补充维生素D,再加上良好的睡眠健康状况,可有效地缓解因关节炎、慢性背部疼痛、纤维肌痛和痛经所致的疼痛。